NOXRED1
gene geneOn this page
Also known as FLJ32809
Summary
NOXRED1 (NADP dependent oxidoreductase domain containing 1, HGNC:20487) is a protein-coding gene on chromosome 14q24.3, encoding NADP-dependent oxidoreductase domain-containing protein 1 (Q6NXP6). Probable oxidoreductase.
Predicted to enable pyrroline-5-carboxylate reductase activity. Predicted to be involved in L-proline biosynthetic process.
Source: NCBI Gene 122945 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 67 total
- MANE Select transcript:
NM_001113475
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20487 |
| Approved symbol | NOXRED1 |
| Name | NADP dependent oxidoreductase domain containing 1 |
| Location | 14q24.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ32809 |
| Ensembl gene | ENSG00000165555 |
| Ensembl biotype | protein_coding |
| Entrez | 122945 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 retained_intron
ENST00000380835, ENST00000555603, ENST00000555901
RefSeq mRNA: 2 — MANE Select: NM_001113475
NM_001113475, NM_001394980
CCDS: CCDS45142
Canonical transcript exons
ENST00000380835 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001486463 | 77394021 | 77394805 |
| ENSE00001486466 | 77405913 | 77406135 |
| ENSE00001486470 | 77406724 | 77406875 |
| ENSE00003555073 | 77422735 | 77423523 |
| ENSE00003595519 | 77407465 | 77407645 |
| ENSE00003669317 | 77413934 | 77414127 |
Expression profiles
Bgee: expression breadth ubiquitous, 156 present calls, max score 84.37.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0066 / max 4.9619, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 144227 | 0.0066 | 3 |
Top tissues by expression
253 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.37 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.65 | gold quality |
| sperm | CL:0000019 | 79.95 | silver quality |
| left testis | UBERON:0004533 | 76.78 | gold quality |
| right testis | UBERON:0004534 | 75.03 | gold quality |
| testis | UBERON:0000473 | 74.23 | gold quality |
| pancreatic ductal cell | CL:0002079 | 70.54 | silver quality |
| right uterine tube | UBERON:0001302 | 67.94 | gold quality |
| tibialis anterior | UBERON:0001385 | 67.64 | silver quality |
| ventricular zone | UBERON:0003053 | 63.38 | gold quality |
| ileal mucosa | UBERON:0000331 | 63.07 | silver quality |
| cortical plate | UBERON:0005343 | 62.38 | gold quality |
| monocyte | CL:0000576 | 61.83 | gold quality |
| right lobe of liver | UBERON:0001114 | 61.42 | gold quality |
| leukocyte | CL:0000738 | 61.33 | gold quality |
| skin of leg | UBERON:0001511 | 61.12 | gold quality |
| right adrenal gland | UBERON:0001233 | 61.08 | gold quality |
| body of pancreas | UBERON:0001150 | 61.06 | gold quality |
| metanephros cortex | UBERON:0010533 | 61.06 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 61.01 | gold quality |
| stromal cell of endometrium | CL:0002255 | 60.94 | gold quality |
| skin of abdomen | UBERON:0001416 | 60.94 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 60.80 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 60.66 | gold quality |
| thyroid gland | UBERON:0002046 | 60.13 | gold quality |
| granulocyte | CL:0000094 | 59.89 | gold quality |
| adenohypophysis | UBERON:0002196 | 59.84 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 59.69 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 59.58 | gold quality |
| pancreas | UBERON:0001264 | 59.36 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.89 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- In the analysis of the genotype tissue expression (GTEx) project datasets, HAL rs17676826 C and NOXRED1 rs8012548 G alleles were significantly associated with their mRNA expression levels in sun-exposed skin of the lower leg (P = 6.62 x 10(-6) and 1.37 x 10(-7) , respectively) and in sun-not-exposed suprapubic skin (P < .001 and 1.43 x 10(-8) , respectively). (PMID:31435991)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | noxred1 | ENSDARG00000027538 |
| mus_musculus | Noxred1 | ENSMUSG00000072919 |
| rattus_norvegicus | Noxred1 | ENSRNOG00000047312 |
| drosophila_melanogaster | P5cr | FBGN0015781 |
| caenorhabditis_elegans | WBGENE00018904 |
Paralogs (3): PYCR3 (ENSG00000104524), PYCR2 (ENSG00000143811), PYCR1 (ENSG00000183010)
Protein
Protein identifiers
NADP-dependent oxidoreductase domain-containing protein 1 — Q6NXP6 (reviewed: Q6NXP6)
Alternative names: Pyrroline-5-carboxylate reductase-like protein C14orf148
All UniProt accessions (2): G3V2D4, Q6NXP6
UniProt curated annotations — full annotation on UniProt →
Function. Probable oxidoreductase.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Similarity. Belongs to the pyrroline-5-carboxylate reductase family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6NXP6-1 | 1 | yes |
| Q6NXP6-2 | 2 |
RefSeq proteins (2): NP_001106946, NP_001381909 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR028939 | P5C_Rdtase_cat_N | Domain |
| IPR036291 | NAD(P)-bd_dom_sf | Homologous_superfamily |
Pfam: PF03807
UniProt features (4 total): sequence conflict 2, chain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6NXP6-F1 | 86.98 | 0.69 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 61 (showing top):
GOBP_GLUTAMINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS, GOBP_ALPHA_AMINO_ACID_METABOLIC_PROCESS, GOBP_AMINO_ACID_BIOSYNTHETIC_PROCESS, GOBP_GLUTAMINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS, GOBP_ORGANIC_ACID_BIOSYNTHETIC_PROCESS, GOBP_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS, chr14q24, GOBP_ORGANIC_ACID_METABOLIC_PROCESS, GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS, GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR, GOBP_PROLINE_METABOLIC_PROCESS, MIR1468_3P, MIR548AW, MIR450B_5P, MIR5584_5P
GO Biological Process (2): L-proline biosynthetic process (GO:0055129), biological_process (GO:0008150)
GO Molecular Function (3): pyrroline-5-carboxylate reductase activity (GO:0004735), molecular_function (GO:0003674), oxidoreductase activity (GO:0016491)
GO Cellular Component (1): cellular_component (GO:0005575)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| L-proline metabolic process | 1 |
| glutamate family amino acid biosynthetic process | 1 |
| oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor | 1 |
| catalytic activity | 1 |
Protein interactions and networks
STRING
746 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NOXRED1 | SLIRP-OT1 | Q8N769 | 608 |
| NOXRED1 | TMEM253 | P0C7T8 | 580 |
| NOXRED1 | TMED8 | Q6PL24 | 575 |
| NOXRED1 | LGSN | Q5TDP6 | 529 |
| NOXRED1 | SAMD15 | Q9P1V8 | 509 |
| NOXRED1 | PYCR3 | Q53H96 | 450 |
| NOXRED1 | TMEM50A | O95807 | 447 |
| NOXRED1 | C6orf89 | Q6UWU4 | 436 |
| NOXRED1 | ALDH18A1 | P54886 | 425 |
| NOXRED1 | C1orf56 | Q9BUN1 | 406 |
| NOXRED1 | AGMAT | Q9BSE5 | 402 |
| NOXRED1 | ADSL | P30566 | 401 |
| NOXRED1 | SLC6A16 | Q9GZN6 | 394 |
| NOXRED1 | UROC1 | Q96N76 | 392 |
| NOXRED1 | ISM2 | Q6H9L7 | 391 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NOXRED1 | MPZL1 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (3): MPZL1 (Affinity Capture-MS), MPZL1 (Affinity Capture-MS), MPZL1 (Affinity Capture-MS)
ESM2 similar proteins: A0JM24, A1A5R7, A2AKG8, A2CI34, D3YWQ0, F1MAB7, F6S215, O08653, O43149, O54705, O62699, P29477, P35608, P59438, P97499, Q06518, Q08DB2, Q20CR4, Q27995, Q28314, Q4R856, Q4TVR5, Q4VSN2, Q4VSN3, Q4VSN4, Q4VSN5, Q5BIW4, Q5EB20, Q5R6T6, Q5SSH7, Q5TEA3, Q5VW36, Q6NV72, Q6NXH8, Q6NXP6, Q6P996, Q6XUX0, Q6XUX1, Q6XUX2, Q6XUX3
Diamond homologs: A0JM24, Q6NXP6, Q9D3S5, A0A348AXY1, A1L2Q8, O04016, O66553, P0A9L8, P0A9L9, P0C1E4, P0C1E5, P17817, P22008, P27771, P32322, P43869, P46725, P52053, P54552, P54893, P54904, P74572, P9WHU6, P9WHU7, Q04708, Q12641, Q17QJ7, Q20848, Q4R531, Q4R6W7, Q53H96, Q58D08, Q58DT4, Q5PQJ6, Q5R9X6, Q5RAQ3, Q5SPD7, Q6AY23, Q922Q4, Q922W5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
67 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 52 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1111 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 14:77406747:G:C | donor_gain | 1.0000 |
| 14:77406786:C:CA | donor_gain | 1.0000 |
| 14:77406700:G:A | donor_gain | 0.9900 |
| 14:77407645:CCTG:C | acceptor_loss | 0.9800 |
| 14:77407646:CTGG:C | acceptor_loss | 0.9800 |
| 14:77407647:T:C | acceptor_loss | 0.9800 |
| 14:77406132:CCCC:C | acceptor_gain | 0.9700 |
| 14:77406133:CCCC:C | acceptor_gain | 0.9700 |
| 14:77406720:TG:T | donor_gain | 0.9700 |
| 14:77406721:G:T | donor_gain | 0.9700 |
| 14:77405916:T:A | donor_gain | 0.9600 |
| 14:77406136:C:CG | acceptor_loss | 0.9600 |
| 14:77406137:T:G | acceptor_loss | 0.9600 |
| 14:77406138:A:C | acceptor_loss | 0.9500 |
| 14:77406717:CCG:C | donor_gain | 0.9400 |
| 14:77406725:A:T | donor_gain | 0.9400 |
| 14:77406718:CG:C | donor_gain | 0.9300 |
| 14:77406133:CCC:C | acceptor_gain | 0.9200 |
| 14:77406134:CCC:C | acceptor_gain | 0.9200 |
| 14:77406787:C:A | donor_gain | 0.9200 |
| 14:77405907:CCTTA:C | donor_loss | 0.9100 |
| 14:77405908:CTTA:C | donor_loss | 0.9100 |
| 14:77405909:TTA:T | donor_loss | 0.9100 |
| 14:77405910:TACCT:T | donor_loss | 0.9100 |
| 14:77405911:A:C | donor_loss | 0.9100 |
| 14:77405912:C:CT | donor_loss | 0.9100 |
| 14:77394806:C:CC | acceptor_gain | 0.9000 |
| 14:77411949:G:C | donor_gain | 0.9000 |
| 14:77414126:CT:C | acceptor_gain | 0.9000 |
| 14:77414128:C:CC | acceptor_gain | 0.9000 |
AlphaMissense
2339 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 14:77407491:G:C | S168R | 0.991 |
| 14:77407491:G:T | S168R | 0.991 |
| 14:77407493:T:G | S168R | 0.991 |
| 14:77407566:G:C | C143W | 0.982 |
| 14:77406112:A:G | W236R | 0.979 |
| 14:77406112:A:T | W236R | 0.979 |
| 14:77407568:A:G | C143R | 0.972 |
| 14:77407573:A:G | F141S | 0.969 |
| 14:77406080:G:C | N246K | 0.968 |
| 14:77406080:G:T | N246K | 0.968 |
| 14:77407549:A:G | L149P | 0.965 |
| 14:77414021:C:A | G88W | 0.964 |
| 14:77422769:C:G | A41P | 0.964 |
| 14:77407563:G:C | C144W | 0.962 |
| 14:77394790:A:C | F307L | 0.960 |
| 14:77394790:A:T | F307L | 0.960 |
| 14:77394792:A:G | F307L | 0.960 |
| 14:77407498:A:T | V166E | 0.959 |
| 14:77407572:G:C | F141L | 0.959 |
| 14:77407572:G:T | F141L | 0.959 |
| 14:77407574:A:G | F141L | 0.959 |
| 14:77407565:A:G | C144R | 0.958 |
| 14:77414035:C:T | G83E | 0.958 |
| 14:77407496:A:C | Y167D | 0.955 |
| 14:77407567:C:T | C143Y | 0.954 |
| 14:77414041:A:G | I81T | 0.954 |
| 14:77414008:G:T | A92D | 0.953 |
| 14:77407586:C:G | A137P | 0.948 |
| 14:77407597:A:G | L133P | 0.947 |
| 14:77414038:A:T | I82N | 0.946 |
dbSNP variants (sampled 300 via entrez): RS1000003882 (14:77424840 G>C), RS1000067040 (14:77401625 G>A), RS1000086100 (14:77417214 C>A,T), RS1000333577 (14:77401273 G>C), RS1000493967 (14:77398636 T>C), RS1000511131 (14:77420596 T>A,C), RS1000562483 (14:77417449 G>A), RS1000648383 (14:77420939 G>A), RS1000675644 (14:77413428 A>G,T), RS1000730235 (14:77406493 G>C), RS1000731175 (14:77405804 T>C), RS1000782689 (14:77427138 C>A), RS1000783154 (14:77406838 G>A), RS1000942010 (14:77399654 T>C), RS1000954091 (14:77412671 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004610_139 | White blood cell count | 2.000000e-09 |
| GCST004614_17 | Granulocyte count | 2.000000e-12 |
| GCST004620_87 | Sum basophil neutrophil counts | 8.000000e-12 |
| GCST004626_128 | Myeloid white cell count | 2.000000e-11 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007987 | granulocyte count |
| EFO:0004833 | neutrophil count |
| EFO:0005090 | basophil count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | decreases expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| Arbutin | decreases expression | 1 |
| Folic Acid | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.